Filters
This advisory introduces readers to cannabidiol (CBD), how it is derived, and how it differs from delta-9 THC and other cannabinoids. The advisory focuses on the risks and harms of CBD, especially those sold over the counter. This advisory also clarifies common misconceptions about CBD, given its broad availability and marketing for several medical conditions despite limited evidence of efficacy.
View ResourceThis brief provides guidelines on prescribing Opioids for Pain.
View ResourceThis guide equips clinicians with information for treating chronic pain in adults living with a history of substance use.
View Resource